Diagnosis and management of pancreatic cancer: A review for physicians

Pancreatic cancer is the fourth leading cause of death from cancer, and while family physicians in Canada only see 1 cases a year, the number of cases is expected to increase as the population ages. A review in CMAJ (Canadian Medical Association Journal) provides an evidence-based overview of diagnosis and treatment of the disease for general physicians.

The main risk factor for pancreatic cancer is smoking, although about 20% of patients have a family history of the disease. Symptoms usually manifest 10 years after the start of the disease, which means screening has theoretical benefits although there are no evidence-based standardized screening protocols. For people with hereditary pancreatic cancer, screening on a limited investigational protocol begins 10 years before the youngest relative was diagnosed or at age 40, whichever comes first. Diagnostic tests include abdominal ultrasounds and CT scans, the latter being used to diagnose the stage of cancer and the location of the position of the tumour in relation to vessels and other organs.

Surgery can be successful for cancers that have not spread beyond the pancreas, with a 5-year survival of 15%, but higher in some cases (25

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.111697

Related Stories

Gene identified in increasing pancreatic cancer risk

date Dec 29, 2011

Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.